These results suggest that BRCA1-competent breast cancer cells are more sensitive, whereas BRCA1-deficient breast cancer cells are less sensitive, to SAHA-induced loss of stemness under normoxic conditions. The gene discussed is BRCA1; the disease is breast cancer.